These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6175774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA.
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
    Alexander GJ, Fagan EA, Rolando N, Guarner P, Callender ME, Eddleston AL, Williams R.
    J Hepatol; 1986 Jan; 3 Suppl 2():S81-6. PubMed ID: 2439580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P, Ouzan D, Degos F, Brechot C, Metman EH, Degott C, Chevalier M, Berthelot P, Trepo C, Benhamou JP.
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM.
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV.
    J Hepatol; 1986 May; 3 Suppl 2():S107-10. PubMed ID: 2439568
    [Abstract] [Full Text] [Related]

  • 12. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, Jones EA, Gerin JL, Ishak K.
    Hepatology; 1982 May; 2(6):784-8. PubMed ID: 6183183
    [Abstract] [Full Text] [Related]

  • 13. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R, Klein H, Vido I, Niehoff G, Lautz HU, Gebel M, Schmidt FW.
    J Hepatol; 1986 May; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract] [Full Text] [Related]

  • 14. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ, Lever AM, Yap I, Pignatelli M, Thomas HC.
    J Hepatol; 1986 May; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
    Garcia G, Smedile A, Bergmann KF, Gerin JL, Gregory PB, Merigan TC, Robinson WS.
    West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.